Outrage over drug price hike

The CEO of Turing Pharmaceuticals is defending his decision to raise the price of the life-saving drug Daraprim from $13.50 to $750 a tablet. Outrage over his decision has spread to the campaign trial and triggered instability on Wall Street. New York Times Reporter Andrew Pollack and Infectious Disease Specialist, Dr. Frank Esper join NewsNation.Sept. 22, 2015